TyraTech set to sell new insect repellent in US
TyraTech enjoyed a bounce after announcing its new insect repellent had been granted registration in the US, leaving it just one step short of being on the shelves.
TyraTech enjoyed a bounce after announcing its new insect repellent had been granted registration in the US, leaving it just one step short of being on the shelves.
The firm's personal insect repellent 'NO-SKEETO!' now has registration in 49 States and the District of Columbia.
This news means the product is approved and ready for immediate sale in retail channels, and caused shares to jump 9.5%.
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
The company is now in the process of evaluating global commercial and retail partners for the product.
It has also filed for patent protection for its NO-SKEETO! formulation and has submitted data from laboratory and field trials for publication in two international journals.
TyraTech's Vice President of Research & Development, Dr. Keith Kennedy, said diseases transmitted by mosquitoes and ticks continued to be an increasing problem in North America.
'The number of West Nile Virus cases reported in the US so far this year was the highest number recorded by the Centers for Disease Control in the last 10 years," he said.
"The incidence of Lyme disease continues to exceed more than 30,000 cases per year."
Sign up to Money Morning
Our team, led by award winning editors, is dedicated to delivering you the top news, analysis, and guides to help you manage your money, grow your investments and build wealth.
-
Saba Capital and Boaz Weinstein respond to investment trusts
As investment trust managers and industry experts accuse Saba of self-motivated opportunism, the hedge fund responds to specific "misleading claims" and sets out its stall
By Dan McEvoy Published
-
How to find top-quality companies with growing dividends
Ian Mortimer, portfolio manager of Guinness Global Equity Income Fund, shares where he would put his money for sustainable and growing dividends
By Ian Mortimer Published